Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human GPCR GPR35 ELISA Kit (AC2979)
Cat.#: ASET-1568
Specifications
Description Human GPCR GPR35 ELISA Kit allows for the in vitro quantitative determination of human GPCR GPR35 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1938 Mouse Neurotrophin 3 ELISA Kit (AC3349) Quantitative inquiry ASET-1889 Human Toca-1 ELISA Kit (AC3300) Quantitative inquiry ASET-2357 Human GBA ELISA Kit (AC3768) Quantitative inquiry ASET-2120 Rat ARNT2 ELISA Kit (AC3531) Quantitative inquiry ASET-2109 Rat beta 1 Adrenergic Receptor ELISA Kit (AC3520) Quantitative inquiry ASET-1400 Mouse Semaphorin 3A ELISA Kit (AC2811) Quantitative inquiry ASET-1420 Human ALDH1A1 ELISA Kit (AC2831) Quantitative inquiry ASET-1565 Human BASP1 ELISA Kit (AC2976) Quantitative inquiry ASET-2490 Human PSPN ELISA Kit (AC3901) Quantitative inquiry ASET-2395 Mouse Nrg2 ELISA Kit (AC3806) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket